Under construction – not a live service
Sign in

2023-508709-26-00RecruitingPhase 2

F-18 PSMA-11 PET for Imaging and Staging of Hepatocellular carcinoma with Evaluation of Survival

Source: EU CTIS (euclinicaltrials.eu) · Last updated 30 Sept 2026

Next steps

Brief summary (registry, in English)

To determine the diagnostic accuracy of F-18 PSMA-11 PET/CT for the (re)staging of hepatocellular carcinoma (HCC) compared to F-18 FDG PET/CT and F-18 Choline PET/CT.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
32 (estimated)
First submitted
29 May 2024
Start date
31 Jul 2026
Lead sponsor
Universitair Ziekenhuis Gent
EU CT number
2023-508709-26-00

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 32
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known active malignancy other than hepatocellular carcinoma.
  • History of prostate cancer

Other

  • Active pregnancy
  • Possible pregnancy and refusal of urine pregnancy test

Who the study is looking for

  • Willing and mentally legally capable to provide written informed consent
  • 18 years of age or older
  • One of the following clinical scenario’s: • New diagnosis of HCC, confirmed either by biopsy or imaging using EASL/AASLD criteria, with a high risk of metastases indicated by portal invasion or a primary lesion of >5cm diameter. • Known diagnosis of HCC that requires restaging due to unexplained elevated AFP tumor markers, known metastases, impending initiation of immunotherapy, or being on the waiting list for a liver transplant.
    • Have either planned or recently undergone (within the past 4 weeks) both F-18 FDG PET/CT and F-18 Choline PET/CT scans as part of their diagnostic or staging workup for one of the above indications.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Universitair Ziekenhuis GentGentBelgiumRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.